Eli Lilly Cdr Stock Performance
| LLY Stock | 38.40 1.40 3.78% |
Eli Lilly has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.85, which means possible diversification benefits within a given portfolio. As returns on the market increase, Eli Lilly's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eli Lilly is expected to be smaller as well. Eli Lilly CDR right now shows a risk of 2.5%. Please confirm Eli Lilly CDR total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to decide if Eli Lilly CDR will be following its price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly CDR are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Eli Lilly is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Eli |
Eli Lilly Relative Risk vs. Return Landscape
If you would invest 3,721 in Eli Lilly CDR on November 9, 2025 and sell it today you would earn a total of 119.00 from holding Eli Lilly CDR or generate 3.2% return on investment over 90 days. Eli Lilly CDR is generating 0.0856% of daily returns assuming 2.4975% volatility of returns over the 90 days investment horizon. Simply put, 22% of all stocks have less volatile historical return distribution than Eli Lilly, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Eli Lilly Target Price Odds to finish over Current Price
The tendency of Eli Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 38.40 | 90 days | 38.40 | about 43.91 |
Based on a normal probability distribution, the odds of Eli Lilly to move above the current price in 90 days from now is about 43.91 (This Eli Lilly CDR probability density function shows the probability of Eli Stock to fall within a particular range of prices over 90 days) .
Eli Lilly Price Density |
| Price |
Predictive Modules for Eli Lilly
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eli Lilly CDR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Eli Lilly Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Eli Lilly is not an exception. The market had few large corrections towards the Eli Lilly's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eli Lilly CDR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eli Lilly within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | 0.85 | |
σ | Overall volatility | 1.11 | |
Ir | Information ratio | -0.0016 |
Eli Lilly Fundamentals Growth
Eli Stock prices reflect investors' perceptions of the future prospects and financial health of Eli Lilly, and Eli Lilly fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eli Stock performance.
| Return On Equity | 96.82 | |||
| Current Valuation | 1.37 T | |||
| Price To Book | 38.95 X | |||
| Price To Sales | 15.69 X | |||
| Earnings Per Share | 20.45 X | |||
About Eli Lilly Performance
By examining Eli Lilly's fundamental ratios, stakeholders can obtain critical insights into Eli Lilly's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Eli Lilly is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Eli Lilly is entity of Canada. It is traded as Stock on TO exchange.Things to note about Eli Lilly CDR performance evaluation
Checking the ongoing alerts about Eli Lilly for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Eli Lilly CDR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Eli Lilly's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Eli Lilly's stock performance include:- Analyzing Eli Lilly's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eli Lilly's stock is overvalued or undervalued compared to its peers.
- Examining Eli Lilly's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eli Lilly's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eli Lilly's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eli Lilly's stock. These opinions can provide insight into Eli Lilly's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Eli Stock
Eli Lilly financial ratios help investors to determine whether Eli Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eli with respect to the benefits of owning Eli Lilly security.